Chimera Investment (CIM) EBITDA (2009 - 2026)

Chimera Investment has disclosed EBITDA across 18 years of filings, most recently posting $168.2 million for Q2 2026.

• In Q2 2026, EBITDA fell 1.73% year-over-year to $168.2 million; the TTM figure through Jun 2026 stood at $592.6 million (down 16.17% YoY), while the FY2025 annual figure was $787.7 million, up 17.15% from the prior year.
• EBITDA came in at $168.2 million for Q2 2026 at Chimera Investment, up from $98.3 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $290.4 million in Q1 2025 to a low of -$198.4 million in Q1 2022.
• Average EBITDA over 5 years is $121.2 million, with a median of $167.7 million recorded in 2023.
• Year-over-year, EBITDA plunged 173.6% in 2022 and surged 1012.67% in 2025.
• Over 5 years, EBITDA stood at $203.8 million in 2022, then fell by 22.92% to $157.1 million in 2023, then slumped by 112.72% to -$20.0 million in 2024, then surged by 1012.67% to $182.3 million in 2025, then decreased by 7.76% to $168.2 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $168.2 million in Q2 2026, $98.3 million in Q1 2026, and $182.3 million in Q4 2025.